The U.S. Federal Trade Commission is expected to file a lawsuit as early as Tuesday to block Amgen Inc.’s $27.8 billion deal to buy Horizon Therapeutics PLC (HZNP.O), a person familiar with the matter told Reuters.
Tag Archive for: Federal Trade Commission (FTC)
A U.S. appeals court on Tuesday said it will accelerate reviewing Illumina Inc’s challenge to a federal agency order requiring the biotechnology company to divest cancer diagnostic test maker Grail LLC.
Martin Shkreli on Friday urged a U.S. judge not to hold him in civil contempt for failing to provide federal and state regulators with information to determine whether he is violating a lifetime ban from working in the pharmaceutical industry.
As the 118th Congress kicks into gear, biopharma industry observers speculate that 2023 may be a challenging year.
U.S. life sciences firm Illumina will have to divest biotechnology company Grail after an EU veto of the $7.1 billion acquisition over concerns it would hurt competition and stifle innovation.
The Federal Trade Commission (FTC) voted unanimously Thursday to increase scrutiny of pharmacy benefit managers that act as middlemen between drug companies and consumers in a renewed effort to combat soaring healthcare costs and drug prices.